Taha Azad

1.7k total citations
37 papers, 1.1k citations indexed

About

Taha Azad is a scholar working on Molecular Biology, Cell Biology and Infectious Diseases. According to data from OpenAlex, Taha Azad has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cell Biology and 6 papers in Infectious Diseases. Recurrent topics in Taha Azad's work include Hippo pathway signaling and YAP/TAZ (12 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and bioluminescence and chemiluminescence research (4 papers). Taha Azad is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (12 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and bioluminescence and chemiluminescence research (4 papers). Taha Azad collaborates with scholars based in Canada, Iran and United States. Taha Azad's co-authors include Xiaolong Yang, Helena J. Janse van Rensburg, Yawei Hao, Saman Hosseinkhani, Amin Tashakor, Prem Khanal, Mina Ghahremani, Ling Min, Charles H. Graham and Brooke Snetsinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Taha Azad

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taha Azad Canada 16 629 469 164 96 93 37 1.1k
Henry E. Pelish United States 10 594 0.9× 208 0.4× 130 0.8× 84 0.9× 38 0.4× 22 913
Javier Muñoz-García France 12 380 0.6× 150 0.3× 145 0.9× 101 1.1× 199 2.1× 23 743
Tomáš Vomastek Czechia 19 674 1.1× 285 0.6× 139 0.8× 46 0.5× 59 0.6× 31 1.0k
Katarzyna M. Kedziora United States 18 568 0.9× 187 0.4× 124 0.8× 45 0.5× 63 0.7× 43 905
Ruud H. Wijdeven Netherlands 16 686 1.1× 414 0.9× 180 1.1× 192 2.0× 39 0.4× 31 1.3k
Benjamin Gibert France 23 1.0k 1.6× 337 0.7× 161 1.0× 144 1.5× 45 0.5× 35 1.4k
Roberta Pascolutti United States 7 559 0.9× 242 0.5× 122 0.7× 98 1.0× 35 0.4× 8 851
Naveid Ali Australia 10 665 1.1× 127 0.3× 163 1.0× 121 1.3× 54 0.6× 13 1.0k
Andreas P. Frei Switzerland 16 942 1.5× 131 0.3× 159 1.0× 261 2.7× 121 1.3× 23 1.4k

Countries citing papers authored by Taha Azad

Since Specialization
Citations

This map shows the geographic impact of Taha Azad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taha Azad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taha Azad more than expected).

Fields of papers citing papers by Taha Azad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taha Azad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taha Azad. The network helps show where Taha Azad may publish in the future.

Co-authorship network of co-authors of Taha Azad

This figure shows the co-authorship network connecting the top 25 collaborators of Taha Azad. A scholar is included among the top collaborators of Taha Azad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taha Azad. Taha Azad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jafari, Kian, et al.. (2025). An Ultrasensitive MOEMS Platform Relied on an Adjustable Defect Width for Label-Free Bioparticle Detection. IEEE Sensors Journal. 25(10). 17309–17316.
2.
Moteshareie, Houman, Taha Azad, Martin Holčı́k, et al.. (2024). Hydrogen peroxide sensitivity connects the activity of COX5A and NPR3 to the regulation of YAP1 expression. The FASEB Journal. 38(5). e23439–e23439. 2 indexed citations
3.
Labouta, Hagar I., et al.. (2024). Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer. Pharmaceutics. 16(9). 1181–1181. 7 indexed citations
4.
5.
Froehlich, Ulrike, Alexandre Murza, Taha Azad, et al.. (2023). Comparative Analysis of Cyclization Techniques in Stapled Peptides: Structural Insights into Protein–Protein Interactions in a SARS-CoV-2 Spike RBD/hACE2 Model System. International Journal of Molecular Sciences. 25(1). 166–166. 1 indexed citations
6.
Martin, Nikolas T., Mathieu J. F. Crupi, Zaid Taha, et al.. (2023). Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. Pharmaceuticals. 16(5). 709–709. 4 indexed citations
7.
Azad, Taha, et al.. (2023). Peptides of a Feather: How Computation Is Taking Peptide Therapeutics under Its Wing. Genes. 14(6). 1194–1194. 21 indexed citations
8.
Azad, Taha, Ragunath Singaravelu, Zaid Taha, et al.. (2021). SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition. Biosensors and Bioelectronics. 180. 113122–113122. 23 indexed citations
9.
Rezaei, Reza, et al.. (2021). Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter. Journal of Visualized Experiments. 2 indexed citations
10.
Homaei, Ahmad, Fábio Vianello, Taha Azad, et al.. (2021). Industrial applications of immobilized nano-biocatalysts. Bioprocess and Biosystems Engineering. 45(2). 237–256. 66 indexed citations
11.
Azad, Taha, Kazem Nouri, Helena J. Janse van Rensburg, et al.. (2019). A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene. 39(2). 334–355. 51 indexed citations
12.
Nouri, Kazem, Taha Azad, Elizabeth D. Lightbody, et al.. (2019). A kinome‐wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion. The FASEB Journal. 33(11). 12487–12499. 34 indexed citations
13.
Zhao, Yulei, Taha Azad, Elizabeth D. Lightbody, et al.. (2018). PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways. Molecular Cancer Research. 16(6). 1046–1058. 56 indexed citations
14.
Rensburg, Helena J. Janse van, Taha Azad, Ling Min, et al.. (2018). The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Cancer Research. 78(6). 1457–1470. 244 indexed citations
15.
Azad, Taha, Helena J. Janse van Rensburg, Elizabeth D. Lightbody, et al.. (2018). A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nature Communications. 9(1). 1061–1061. 127 indexed citations
16.
Azad, Taha, et al.. (2015). Oscillation of apoptosome formation through assembly of truncated Apaf-1. European Journal of Pharmacology. 760. 64–71. 9 indexed citations
17.
Hemmati, Roohullah, Saman Hosseinkhani, Reza H. Sajedi, et al.. (2015). Luciferin‐Regenerating Enzyme Mediates Firefly Luciferase Activation Through Direct Effects of D‐Cysteine on Luciferase Structure and Activity. Photochemistry and Photobiology. 91(4). 828–836. 16 indexed citations
18.
Azad, Taha, Amin Tashakor, Mina Ghahremani, et al.. (2014). Apoptotic protease-activating factor 1 (Apaf-1) as a liable gene for spontaneous mutations in vitro. 4(2). 261–273. 1 indexed citations
19.
Ghahremani, Mina, et al.. (2014). Ornithine-induced increase of proline and polyamines contents in tobacco cells under salinity conditions. Australian Journal of Crop Science. 8(1). 91–96. 8 indexed citations
20.
Ghahremani, Mina, Faezeh Ghanati, Françoise Bernard, Morteza Gholami, & Taha Azad. (2013). Effects of exogenous ornithine enantiomers on tobacco cells under salinity conditions. 3(1). 100–107. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026